COPM-Based Goal Setting Strategies in the PICU

March 9, 2026 updated by: Jeong Yi Kwon, Samsung Medical Center

Development and Feasibility Evaluation of Canadian Occupational Performance Measure-Based Goal Setting Strategies for Pediatric Intensive Care Unit Patients: A Multi-Phase Mixed-Methods Study

COPM-Based Goal Setting Strategies in the PICU

Study Overview

Study Type

Interventional

Enrollment (Estimated)

5

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Seoul, South Korea, 06351
        • Not yet recruiting
        • Samsung Medical Center
        • Contact:
    • Gangnam-gu
      • Seoul, Gangnam-gu, South Korea, 06351
        • Recruiting
        • Samsung Medical Center
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Phase 1-2 (Delphi Survey - Experts)

  • Physicians specializing in pediatrics or physical medicine and rehabilitation, occupational therapists, physical therapists, and nursing staff
  • Minimum of 2 years of direct clinical experience in a Pediatric Intensive Care Unit (PICU)

Phase 3 (Pilot Testing - Caregivers & PICU Clinicians)

Caregivers:

  • Legal guardian of a child aged 1-18 years admitted to PICU
  • ≥24 hours post-admission

PICU clinicians:

- Treating occupational or physical therapist involved in the child's care during PICU admission

Exclusion Criteria:

Phase 1-2 (Delphi Survey - Experts)

  • Rehabilitation professionals without prior PICU clinical experience
  • Inability to read or respond to Korean-language surveys

Phase 3 (Pilot Testing - Caregivers & PICU Clinicians)

  • Caregivers experiencing severe emotional distress, or deemed inappropriate for participation by the treating clinician
  • Non-Korean-speaking caregivers
  • Refusal or withdrawal of informed consent at any stage

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Standard physical and occupational therapy
Participants will receive standard physiacal and occupational therapy as routinely provided in the PICU. The therapy may include activities of daily living training, positioning, range of motion exercises, and caregiver education, according to each patient's condition. No experimental intervention is introduced; the study focuses on evaluating patient-centered outcomes using the Canadian Occupational Performance Measure.
Participants admitted to the Pediatric Intensive Care Unit (PICU) will receive standard occupational therapy as part of routine clinical care. Interventions will be tailored to each patient's medical status and functional needs and may include activities of daily living (ADL) training, positioning, range of motion exercises, sensory stimulation, and caregiver education. No additional experimental treatment will be introduced for study purposes. The primary focus of the study is to evaluate patient-centered outcomes using the Canadian Occupational Performance Measure (COPM), without altering the standard therapeutic approach.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Consensus Level for COPM Implementation Criteria in the PICU (Delphi Survey)
Time Frame: From initial Delphi invitation to completion of second round (estimated 2-3 weeks).
Level of expert consensus on specific clinical and procedural criteria for implementing COPM-based goal-setting in PICU, measured via a two-round online Delphi survey. Consensus is defined as ≥70% agreement (≥6/10 on a Likert scale) and mean score ≥7 for Likert items, or ≥50% selection for categorical items.
From initial Delphi invitation to completion of second round (estimated 2-3 weeks).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Client-Centredness of Goal Setting (C-COGS)
Time Frame: Immediately after pilot intervention completion.
C-COGS questionnaire will assess the extent to which client-centred principles are reflected in goal-setting for PICU caregivers. The tool includes 13 items across two subscales: Participation (9 items, max 45 points) and Goal Subscale (up to 24 items). Total scores range from 0-50, with higher scores indicating greater client-centredness.
Immediately after pilot intervention completion.
Caregiver Perceived Acceptability and Feasibility of COPM-Based Goal Setting in PICU
Time Frame: Immediately after pilot intervention completion.
Structured survey developed for this study, based on items from MPOC-20, to assess caregiver perceptions of acceptability, feasibility, and perceived clinical relevance of the COPM-based goal-setting strategy. The survey includes 9 items (7 quantitative on 5-point Likert scale, 2 open-ended for qualitative analysis). Higher scores indicate greater perceived acceptability and feasibility.
Immediately after pilot intervention completion.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 29, 2025

Primary Completion (Estimated)

November 30, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

August 13, 2025

First Submitted That Met QC Criteria

August 13, 2025

First Posted (Actual)

August 19, 2025

Study Record Updates

Last Update Posted (Actual)

March 10, 2026

Last Update Submitted That Met QC Criteria

March 9, 2026

Last Verified

August 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared. The dataset includes sensitive clinical information from PICU patients and their caregivers. Due to concerns about patient privacy, potential re-identification risk, and institutional review boardrestrictions, IPD will be used solely for the purposes defined in the approved protocol and will not be made available for external access.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Illness

Clinical Trials on Standard physical and occupational therapy

Subscribe